Fu, Yujie
Liu, Connor J.
Kobayashi, Dale K.
Johanns, Tanner M.
Bowman-Kirigin, Jay A.
Schaettler, Maximilian O. http://orcid.org/0000-0001-7545-6342
Mao, Diane D.
Bender, Diane
Kelley, Diane G.
Uppaluri, Ravindra http://orcid.org/0000-0001-5988-6828
Bi, Wenya Linda http://orcid.org/0000-0002-4635-0247
Dunn, Ian F.
Tao, Yu
Luo, Jingqin http://orcid.org/0000-0003-2759-3072
Kim, Albert H.
Dunn, Gavin P.
Article History
Received: 24 January 2019
Accepted: 8 May 2020
First Online: 3 June 2020
Competing interests
: Dr. Dunn is a founder and holds equity in Immunovalent Therapeutics. This manuscript received no support from this entity, and there is no overlap with Immunovalent’s focus. The authors have no other competing interests as defined by <i>Nature Research</i>, or other interests that might be perceived to influence the results and/or discussion reported in this paper.